RxDoctor Payments Data

Leah Broyles, NP

Family · Marion, INNPI 1750163960

Payments from drug & device makers

$407in general payments, 2019–2025

Across 19 payments — averaging $21.43 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AstraZeneca$185
  • AbbVie$64
  • GSK$31
  • Novo Nordisk$28
  • Lilly USA, LLC$19
  • Daiichi Sankyo Inc.$18
  • plus $62 from 4 others

What the payments were for

  • Food & beverage$407100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$407 in reported general payments places this provider in the 50th percentile of 4,392 family providers in Indiana.

See all family providers in Indiana

Medicare billing

Part B allowed, 2024
$28,747
Medicare patients
262
Services billed
427

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
EliquisApixaban12$17,647
OzempicSemaglutide13$12,484
Albuterol Sulfate HfaAlbuterol Sulfate44$887
Duloxetine Hcl12$686
Omeprazole38$629
Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav98$596
Doxycycline Monohydrate36$590
Potassium Chloride18$517
Gabapentin31$466
Ondansetron OdtOndansetron15$443
Cephalexin21$419
Levothyroxine Sodium27$342
Tamsulosin Hcl11$336
Nitrofurantoin Mono-MacroNitrofurantoin Monohyd/M-Cryst34$325
Hydroxyzine Hcl16$274

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
PfizerEliquis$14$17,64712 claims
Novo NordiskOzempic$28$12,48413 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 50th percentile of 4,392 family providers in Indiana.

Other family in Marion

See the full list for Indiana

Where these figures come from

Is this you, or does something look wrong? →